AI assistant
IRADIMED CORP — Director's Dealing 2021
Aug 4, 2021
32324_dirs_2021-08-04_a2cc7c6b-1284-4fb8-90dc-51b84ec2c5e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-08-03
Reporting Person: ALLEN MONTY K (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-03 | Common Stock | M | 5000 | $7.1 | Acquired | 21375 | Direct |
| 2021-08-03 | Common Stock | S | 4597 | $34.08 | Disposed | 16778 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-03 | Stock Option (Right to Buy) | $7.1 | M | 5000 | Disposed | Common Stock (5000) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $34.00 to $34.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This option, representing a right to purchase a total of 10,000 shares, was granted on 9/29/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.